Everest Organics Ltd was founded in Hyderabad in February 1993 by S K Srihari Raju and S K Chittiramabhadra Raju. The company specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) and their intermediaries. Operations commenced in 1993 with the establishment of a manufacturing plant in Aroor, Andhra Pradesh, dedicated to producing bulk drugs and formulations. In January 1995, the company went public to secure funding for its projects.
Commercial production of ciprofloxacin and omeprazole began in February 1996. Initially intending to manufacture para hydroxy phenyl glycine (PHPG), the company later decided to pivot due to market conditions, opting instead to increase the capacity of ciprofloxacin from 30 tpa to 120 tpa and to diversify into the production of enrofloxacin/naproxen. Additionally, the company boosted its installed capacity of Benzimidazole by 60 tpa, reaching a total of 120 tpa.
The capacity of Omeprazole Op Sulphide was also expanded from 15 TPA to 30 TPA. In 2007-08, the company expanded its product range with the introduction of Esomeprazole Magnesium, achieved through investments in new facilities and machinery.
Commercial production of ciprofloxacin and omeprazole began in February 1996. Initially intending to manufacture para hydroxy phenyl glycine (PHPG), the company later decided to pivot due to market conditions, opting instead to increase the capacity of ciprofloxacin from 30 tpa to 120 tpa and to diversify into the production of enrofloxacin/naproxen. Additionally, the company boosted its installed capacity of Benzimidazole by 60 tpa, reaching a total of 120 tpa.
The capacity of Omeprazole Op Sulphide was also expanded from 15 TPA to 30 TPA. In 2007-08, the company expanded its product range with the introduction of Esomeprazole Magnesium, achieved through investments in new facilities and machinery.
